Navigation Links
Source Precision Medicine, Inc., dba SourceMDx Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of Finn, Warnke & Gayton, LLP
Date:3/1/2011

WELLESLEY HILLS, Mass., March 1, 2011 /PRNewswire/ -- Source Precision Medicine, Inc., dba SourceMDx ("SourceMDx") has assigned all its assets to Joseph F. Finn, Jr., C.P.A. ("Finn") of the firm Finn, Warnke & Gayton, LLP to be liquidated for the benefit of SourceMDx creditors.

Source MDx® is an industry leader in developing simple blood tests that can consistently detect the presence and aggressiveness of cancer by measuring specific RNA transcripts in blood. RNA is an early biological measure of disease, providing a significant indicator of disease onset or progression in the blood stream before other clinical manifestations become observable. Source MDx® is the first to translate robust RNA-transcript based assays into clinically useful oncology molecular diagnostic tests using a simple, non-invasive blood test. Source MDx® tests are precise and calibrated measurements of white blood cell gene expression and track an individual's current health, disease status and response to therapy in a reproducible fashion.

The intellectual property, patents, etc. will be sold at a sealed bid sale on Friday, April 29, 2011 at noon.

Persons interested in bidding must sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's Office - jffinnjr@finnwarnkegayton.com or 781-237-8840. They will then receive a bid package.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm, Finn, Warnke & Gayton  (www.finnwarnkegayton.com), Certified Public Accountants of Wellesley Hills, Massachusetts. He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as assignee for the benefit of creditors and liquidating agent for a corporation. He has been involved in a number of loan workouts and bankruptcy
'/>"/>

SOURCE Joseph F. Finn, Jr., C.P.A.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Resource Available for People With Lymphoma
2. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
3. NTMir Announces Research Grants for Epidemiology and Household Water as Source of Infection
4. Trojan(R) and the National Sexuality Resource Centers Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health
5. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
6. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
7. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
8. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
9. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
10. June 2008 Mayo Clinic Womens HealthSource Highlights Shingles Vaccine for Pain Prevention, Tips to Avoid Antibiotic Resistant Infections, and Benefits of Broad Genetic Testing
11. McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... April 1, 2015 International Isotopes Inc. (OTCQB: ... year ended December 31, 2014.  The Company reports a ... loss, and positive cash flow for the year ended ... in 2014 was approximately $7.5 million compared to approximately ... approximately 10%.  With the exception of the radiological services ...
(Date:4/1/2015)... 2015 LifeScienceIndustryResearch.com announces ... Industry and 2015 Deep Research Report on ... Pharmaceutical category in its database.  ... basic information, including definition, classification, application, industry ... news analysis, etc. Azithromycin Key Manufacturers Analysis ...
(Date:4/1/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Glucose Clamp Study. The study will be performed at ... San Antonio and University Health System,s ... Ralph DeFronzo . The glucose clamp is ...
Breaking Medicine Technology:International Isotopes Inc. Announces 2014 Year End Financial Results 2International Isotopes Inc. Announces 2014 Year End Financial Results 3International Isotopes Inc. Announces 2014 Year End Financial Results 4International Isotopes Inc. Announces 2014 Year End Financial Results 5International Isotopes Inc. Announces 2014 Year End Financial Results 6International Isotopes Inc. Announces 2014 Year End Financial Results 7Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3
... Reportlinker.com announces that a new market research report is available ... http://www.reportlinker.com/p0324750/Virtual-Pharma.html ... in the pharmaceutical market has slowed – almost to a ... cutting costs in a faltering world economy. ...
... NEW YORK, Nov. 3, 2010 Pfizer Inc. (NYSE: ... public to view and listen to a webcast of ... Primary Care, at the 2010 Annual Credit Suisse Healthcare ... Mountain Standard Time. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) ...
Cached Medicine Technology:Reportlinker Adds Virtual Pharma 2Reportlinker Adds Virtual Pharma 3Reportlinker Adds Virtual Pharma 4Reportlinker Adds Virtual Pharma 5Reportlinker Adds Virtual Pharma 6
(Date:4/1/2015)... IQ Formulations , one of the most highly regarded ... U.S., today is commending GNC for taking steps to boost ... herbal supplements.* GNC vowed that its new processes will look ... labeling on its products. , In response to this ... Jay Cohen said: , “In a lightly-regulated industry where ...
(Date:4/1/2015)... April 01, 2015 eMindful , ... expansion of its executive team with the addition of ... officer. , In his new role, Suissa ... user interface across the business and consumer portals. He ... building the company’s online community. His hiring was ...
(Date:4/1/2015)... PA (PRWEB) April 01, 2015 Health ... company and a subsidiary of West Corporation, today launched ... at http://blog.healthadvocate.com and through the Health Advocate ... healthcare consumers get, and stay, healthy. , “We’re pleased ... available to the public,” said Martin Rosen, Executive Vice ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Dr. ... and Distinguished Teaching Professor of the Department of Plastic ... other doctors to review reports of blindness resulting from ... surgery . The group published their study, along with ... Reconstructive Surgery journal. , "We began to see increasing ...
(Date:4/1/2015)... Sheboygan, WI (PRWEB) April 01, 2015 ... or dryness occur, waiting days or weeks for an ... wants. Historically same and next day appointments haven’t been ... Falls area, Forefront Dermatology’s offices have noticed demand for ... , “We realize how important relief or answers ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3Health News:Health Advocate Launches New Health and Wellness Blog 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2
... ... 70 Percent, IRVINE, Calif., Oct. 31 Endocare, Inc.,(Nasdaq: ... the,development of minimally invasive technologies for tissue and tumor,ablation, reported ... margins resulted in a reduction,in operating loss in the third ...
... StemCor Systems, Inc., a,medical device company developing ... it has received 510(k) clearance from,the U.S. ... its MarrowMiner(TM),for the harvest of bone marrow. ... clearance of StemCor,s MarrowMiner is a major,accomplishment ...
... Statistical Significance, IRVINE, Calif., Oct. 30 ... Biotech, today,announced that the Phase 3 SPARC trial ... did not meet its primary,efficacy endpoint. "We ... for,satraplatin did not achieve statistical significance. Drug development ...
... NY) Researchers at the Albert Einstein College of ... time that cancers can be successfully treated by targeting ... in the October 31 issue of PloS One, also ... cells before they turn cancerous. , The Einstein researchers ...
... Corporation,(Nasdaq and OMX Nordic Exchange: EPCT) today announced that ... Acumen BioFin Rodman & Renshaw,9th Annual Healthcare Conference on ... New York Palace Hotel in New York. Mr. Talley ... ) The presentation will be available live via ...
... Oct. 30 Florida already allows it. And new,research ... the,authority to independently prescribe prescription drugs, a move which ... in 2006 to,$145 billion by 2012, according to Prescribing ... Information. The study shows that 77% of drug ...
Cached Medicine News:Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 2Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 3Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 4Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 5Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 6Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 7Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 8Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 9Health News:StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System 2Health News:StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System 3Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 2Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 3Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 2Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 3Health News:EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Health News:EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3Health News:By 2012, Prescribing Pharmacists Could Influence $145 Billion in Drug Sales 2
This blanket is ideal for warming the large child or small adult during upper body surgery....
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: